The purpose of this study was to compare single arc volumetric modulated arc therapy (VMAT) to intensity modulated radiotherapy (IMRT) for spine SBRT in terms of target coverage, organ at risk (OAR) sparing and delivery performance. VMAT plans with 91 control points (VMAT-91CP) were generated for 15 spine metastases patients previously treated with a nine-field IMRT technique.
Introduction
Spinal metastases occur in approximately 40% of all cancer patients (1). Traditionally, patients have been treated with low dose conventional radiation; however, recently stereotactic body radiation therapy (SBRT) has emerged as an efficacious Technology in Cancer Research & Treatment, Volume 11, Number 6, December 2012 and safe alternative for selected spine patients (2). The aim is to deliver a high biologically effective dose (BED) in few fractions to achieve permanent local tumor control and pain relief (2). Spine SBRT developed with the advent of intensitymodulated radiation therapy (IMRT), and robotic linac-based technology, permits the precise delivery of highly conformal concave dose distributions with steep dose gradients adjacent to critical organs at risk (OAR) (2, 3). However, these technologies are limited such that patients are subject to treatment times that can range from 45 to 90 minutes depending on the complexity of the case and dose-fractionation (4). Long treatment times result in both non-random systematic patient drift and random motions associated with patient discomfort, and these motions compromise precision (5) . In order to maintain sub-millimetre delivery precision and compensate for intrafraction motion, intra-fraction image-guidance is required with strict repositioning thresholds (5, 6) . The frequency of cone-beam CT for spine SBRT has been suggested at approximately every 15-20 minutes and, although effective, CBCT intra-fraction imaging prolongs overall treatment time (6). Therefore, technologies that can reduce treatment time are highly valued for this application.
Recently, volumetric modulated arc therapy (VMAT) has been integrated into mainstream radiation oncology and represents a novel plan optimization and treatment delivery method. VMAT allows a much more efficient delivery of IMRT in a single (or few) dynamically modulated arc (7) (8) (9) (10) (11) (12) (13) (14) . The purpose of this study was to evaluate the technology's ability to plan spine SBRT in a single arc by comparing treatment plans to those treated with IMRT cases as per our established technical approach (15), and specifically determine the impact on treatment time. We hypothesize at least equivalent treatment planning ability, however, with a reduction in treatment time that would eliminate the need for an intra-fraction CBCT. We also evaluated delivery performance by measuring planned-todelivered dose agreement using two different patient-specific dosimeters, and the impact of the control point (CP) gantry angular spacing used in the treatment planning system (TPS) on the planned-to-delivered dose agreement.
Materials and Methods
Fifteen patients previously treated with spine SBRT using IMRT were retrospectively re-planned using VMAT. Treatment sites ranged from C2 to L2 spine lesions in patients without any clinical evidence of spinal cord compression (Table I) . For each IMRT case, an attending physician contoured the clinical-target volume (CTV), the spinal cord and other appropriate organs at risk (OARs) based on CT and registered MR images. The CTV was expanded by 2 mm in all directions to create the planning-target volume (PTV), however, restricted such that no overlap with the spinal cord was permitted. The prescribed dose varied from 18 Gy in a single fraction to 20-30 Gy in 5 fractions (Table I) . Limits on the maximum spinal cord dose varied amongst the plans depending on the indication (the existence of previous treatment, number of fractions and length of CTV/PTV). For all plans, spinal cord sparing superseded PTV coverage with respect to planning priority.
The IMRT and VMAT treatments plans were generated on a commercially available treatment planning system (TPS, Pinnacle 3 , version 8.0 and 8.9, Philips Medical Systems, Madison, WI). All plans were designed for an Elekta Synergy S linear accelerator with a 4 mm multileaf collimator (MLC) leaf width (Elekta Inc., Crawley, UK). The step and shoot IMRT plans used 9 coplanar beams approximately evenly distributed around the target every 408 of gantry angle. A total of 60-70 MLC segments were generated per plan with a minimum segment area of 2 cm 2 . The VMAT plans consisted of a single 3608 arc simulated in the TPS with 91 control points (CPs) evenly spaced every 48 of gantry angle. Collimator angles of 08 and 458 were assessed during the planning optimization process, and better dose distribution were obtained for the majority of our plans (13 out of 15) using the 45-degree collimator angle (11). These plans will be referred to as VMAT-91CP plans from this point forward. The IMRT dose prescription and regions of interest were used for the VMAT-91CP plans. During the VMAT optimization, the planner attempted to achieve the same dose limits to the OARs as the IMRT plans while maximizing the PTV coverage. All plans were computed in the TPS with a calculation grid resolution of 2 3 2 3 2 mm 3 . The VMAT-91CP plans were also modified by increasing the number of CP to 181 using linear interpolation (referred to as VMAT-181CP plans). The MLC shape for an interpolated CP corresponded to the average MLC aperture for the two neighbouring CPs. The interpolated CPs were assigned 25% of the monitor units (MU) from each bounding CPs, while those CPs had their MU values reduced by half. The VMAT-181CP plans were used to assess the impact of the CP gantry angular spacing used in the TPS on the calculated dose distribution, and on the plannedto-delivered dose agreement.
To establish common ground between the VMAT-91CP and IMRT plans, the total number of MU for each VMAT-91CP plan was first adjusted to match the target dose coverage achieved with IMRT to 80% of the PTV volume. IMRT and VMAT-91CP plans were then compared in terms of target coverage and spinal cord sparing using three dosimetric parameters: PTV volume receiving 95% of the prescribed dose (V 95% ), maximum spinal cord dose (D max-cord ) and maximum plan dose (D max-plan ). Dose limits to other OARs such as kidneys or oesophagus were included in the VMAT optimization but were not considered in the plan comparison as they were not common to all plans. The amount of dose delivered to the normal tissue with each technique was assessed by estimating the volume of the patient external contour receiving 20%, 40%, 60% and 80% of prescribed dose (V 20% to V 80% ). Delivery efficiency for both techniques was assessed by comparing the delivery time and the total number of monitor units (MU) for IMRT and VMAT. To facilitate the VMAT to IMRT comparison and eliminate inter-plan variation, ratio of VMAT to IMRT results were calculated for each dosimetric and efficiency parameters. Improved target coverage with VMAT will generate a VMAT/ IMRT ratio .1 for V 95% , while a better spinal cord sparing and a lower maximum dose plan with VMAT will lead to a VMAT/IMRT ratio ,1 for D max-cord and D max-plan , respectively. Differences observed for those parameters between VMAT-91CP and IMRT plans were assessed for significance using the Wilcoxon signed-rank test.
The agreement between the planned and delivered dose for IMRT, VMAT-91CP, and VMAT-181CP plans were assessed using two commercial dosimeters designed for patient-specific quality control (QC): the ArcCHECK (Sun Nuclear Corporation, Melborn, Fl) and the Delta4 (Scandidos, Uppsala, Sweden). The ArcCHECK consists of a hollow cylinder of 26.5 and 15 cm of external and internal diameters with 1386 diodes embedded in the phantom wall (prototype made of solid water) on a cylindrical surface of 20.8 cm of diameter and 21 cm length. The diodes are distributed in a helical pattern with 1 cm spacing both along the spiral length and circumference. The Delta4 is a 22 cm diameter cylindrical phantom made of polymethylmethacrylate (PMMA) with 1069 diodes located on two quasi orthogonal planes passing through the center of the cylinder. The diodes are distributed in a grid pattern of 20 3 20 cm 2 with 5 and 10 mm spacing in the central (6 3 6 cm 2 ) and periphery region, respectively.
In preparation for the measurements, both dosimeters were calibrated to take into account the diode variation in radiation sensitivity as a function of gantry angle using an in-house method for the ArcCHECK (16), and the manufacturer procedure for the Delta4.
For all measurements presented in this report, both dosimeters were setup with the phantom axis parallel to the gantry axis of rotation and levelled with the room lasers. The Arc-CHECK was mounted at the end of the treatment unit couch (Elekta Synergy, Elekta, Crawley, UK) while the Delta4 was resting on it. A CBCT scan was then acquired and registered automatically to a reference planning CT of the phantom using the XVI software (Elekta, Crawley, UK). The locations of the diode assemblies and the phantom external contours were used to verify the registration. Care was taken to eliminate the rotation in the phantom setup and this was confirmed with the image registration. Once the phantom setup corrections were determined, the couch was remotely translated to align the axis of the cylinder with the treatment unit isocenter. The phantom setup was unchanged between deliveries of different plans for a given patient.
Both dosimeters were used in integration mode to measure the composite dose distribution for a given IMRT or VMAT plan. The apparent density of the diode assemblies was overridden and given the density of the surrounding material (1.03 and 1.2 g/cm 3 for the ArcCHECK and the Delta4, respectively) for all TPS calculations performed in this report, to avoid a potential overcorrection due to imaging artifacts. The agreement between calculated and measured doses was assessed using the gamma analysis algorithm (17) available in the dosimeter's software in terms of the relative number of diodes (pass rate) which satisfied specified tolerances of dose difference (%∆D) and distance to agreement (DTA). For the ArcCHECK, the %∆D tolerance was expressed as a function of the computed dose at a given diode location, and a maximum absolute dose difference (∆D of 1 cGy) was used as an alternative pass criterion for low dose points. The %∆D tolerance for the Delta4 follows the Van Dyk formalism (18), and was computed as a function of the maximum dose in the composite distribution. The measurement points corresponding to 10% of the maximum dose in the composite dose distribution were excluded from the comparison to reduce favourable bias associated with low dose regions.
The impact of the CP gantry angular spacing used in the TPS on the planned-to-delivered dose agreement was assessed by comparing for each spine case the pass rates obtained for VMAT-91CP and VMAT-181CP plans. This comparison was performed for both phantom results. For the ArcCHECK, the measurements for the VMAT-91CP plans were also compared to the corresponding dose distribution calculated with 181CPs in an attempt to isolate the CP gantry angular spacing effect (TPS) from the linear accelerator performance. Finally, differences in V 95% , D max-cord and D max-plan between the VMAT-91CP and VMAT-181CP plans were correlated using canonical regression (19) to the difference in pass rate observed for these plans with a given phantom to assess the phantom sensitivity to variation in CP gantry angular spacing used in the TPS.
Results
Single-arc VMAT-91CP plans achieved PTV coverage equivalent to the IMRT plans ( Figure 1A) , with a mean VMAT to IMRT V 95% ratio of 1.1 6 0.2 [standard deviation (SD)] (p 5 0.099). Cord sparing was slightly improved with the use of single-arc VMAT-91CP compared to the IMRT plans ( Figure 1B) with a mean D max-cord ratio (VMAT-91CP/IMRT) of 0.9 6 0.1, and this was statistically significant (p , 0.01). The corresponding mean D max-cord for the VMAT-91CP and IMRT plans were 878 cGy and 946 cGy, respectively. The equivalent PTV coverage and the improved spinal cord sparing with VMAT did not lead to a compromise in maximum plan dose. No significant difference in D max-plan was observed for the VMAT-91CP and IMRT plans with a ratio 1.00 6 0.04 ( Figure 1C ). An example of isodose distribution and dose volume histogram comparison between IMRT and VMAT is shown for one of the 15 cases in Figure 2 and demonstrates the similarity of these plans.
In terms of dose to normal tissues, the single-arc VMAT-91CP technique was as efficient as or better than our IMRT technique within both the low and intermediate dose range (Table II) . This is reflected by the mean VMAT-91CP to IMRT V 20% ratio observed of 1.0 6 0.1 (p 5 0.132). Furthermore, we observed small but non-significant improvements favouring the mean VMAT-91CP at the V 40% , V 60% and V 80% dose levels with a mean ratio of 0.9 6 0.1 for all three dose levels, respectively.
Significant improvements in delivery efficiency were observed with the VMAT-91CP plans as compared to IMRT with a reduction in delivery time of 63% 6 5% (p , 0.01) ( Figure 3A) . For the VMAT-181CP plans the gain in delivery efficiency was slightly smaller with a reduction in delivery time of 53% 6 6% as compared to IMRT. Both VMAT-91CP and VMAT-181CP plans had the same total number of MUs, which was on average 23% 6 12% (p , 0.01) smaller than the IMRT plans ( Figure 3B ).
The planned-to-delivered dose agreement for the 15 IMRT plans was good with an average pass rate of 93.7% 6 2.0% and 99.0% 6 1.3% (%∆D and DTA of 3%/2 mm) for the ArcCHECK and the Delta4, respectively ( Figure 4A and B) . For the VMAT-91CP plans, the ArcCHECK pass rate (same tolerances) was systematically lower with a mean pass rate of 87.6% 6 5.0%, and this difference of pass rate with IMRT was statistically significant (p 5 0.001). The reduction in pass rate for the Delta4 was not as large and was not consistent for all the 15 VMAT-91CP cases (mean of 96.9% 6 3.7%), but still statistically significant (p 5 0.003) as compared to IMRT results. Decreasing the CP angular spacing from 48 to 28 in the TPS for the VMAT-181CP plans using linear interpolation (no re-optimization) significantly improved the planned-todelivered dose agreement. On average, the pass rates for the VMAT-181CP plans were as good as the IMRT results with 93.9% 6 2.7% and 99.1% 6 1.1% for the ArcCHECK and the Delta4, respectively ( Figure 4A and B) . For the Arc-CHECK, the comparison of the VMAT-91CP measured dose to the VMAT-181CP calculated dose also showed pass rates (93.5% 6 2.8%) very similar to the IMRT results. Therefore, Table II Relative volume of normal tissue receiving 20% to 80% of the prescribed dose for the 15 IMRT, VMAT-91CP and VMAT-181CP plans included in this study (V 20% to V 80% ). The volume of normal tissue receiving a given dose level is expressed as a percentage of the patient external contour.
Mean6std IMRT 18.0 6 6.4 6.6 6 3.2 3.1 6 1.6 1.8 6 0.9 VMAT-91CP 17.2 6 6.8 6.0 6 3.1 2.9 6 1.6 1.7 6 0.9 VMAT-181CP 17.2 6 7.0 5.9 6 3.1 2.9 6 1.6 1.7 6 0.9
Range IMRT 8.7-27.2 1.9-13.3 0.9-6.1 0.5-3.3 VMAT-91CP 6.0-32.0 1.9-13.0 0.9-5.9 0.5-3.2 VMAT-181CP 6.0-33.1 1.9-13.1 0.9-5.9 0.5-3.2 the improvements observed in the planned-to-delivered dose agreement by reducing the CP angular spacing was due to a more accurate simulation of the continuous arc delivery in the TPS, and did not depend on a difference in machine delivery performance.
The reduction in CP angular spacing in the TPS to better simulate the continuous arc delivery also had an impact on the calculated dose distributions. The VMAT-181CP plans showed a slightly better PTV coverage (V 95% ) than the VMAT-91CP plans with respect to IMRT results ( Figure 1A) . D max-cord and D max-plan compared well with the IMRT results but the differences were not statistically significant ( Figure 1B and C) .
The largest impact of the increase in number of CPs per plan was observed for patient #13. In this case, the VMAT-91CP plan under-estimated the D max-cord by 262 cGy compared to the VMAT-181CP plan (D max-cord 5 946 and 1208 cGy for the VMAT-91CP and 181VMAT-CP plans, respectively). This substantial increase in D max-cord with the reduction in CP angular spacing (48 to 28) was due to a discretization effect in the TPS which is illustrated in Figure 5 . In this example, the VMAT-91CP plan D max-cord was under-estimated as the beam aperture went from the left side of the PTV (in red in Figure 5 , CPs at 2248 and 2288 of gantry angle) to its right side (CPs at 2248 and 2288 of gantry angle) assuming that the spinal cord remained mostly shielded. The VMAT-181CP plan estimated more accurately D max-cord as it simulated more closely the beam aperture trajectory crossing over the spinal cord (CP at gantry angle 2308, Figure 5 ) as performed by the treatment unit.
Phantom sensitivity to variation in CP angular spacing in the TPS was assessed using canonical regression analysis, which explores relationships between two groups of variables. Variation in pass rate with the reduction of CP angular spacing from 48 to 28 was shown to correlate for both phantoms with the variation in V 95% , D max-cord and D max-plan between VMAT-91CP and VMAT-181CP plans. The ArcCHECK results demonstrated the strongest correlation with a canonical correlation coefficient of 0.8978 (p-value 5 0.0003) compared to the Delta4 with a 0.7807 (p-value 5 0.0128). The sensitivity of the ArcCHECK to the discretization effect observed in the TPS was higher than the Delta4 sensitivity, as only the variation in ArcCHECK pass rates remained statistically correlated to the variation in V 95% , D max-cord and D max-plan after excluding patient #13's results which showed the largest difference in D max-cord between VMAT-91CP and VMAT-181CP.
Figure 4:
The agreement between the planned and delivered dose for IMRT and VMAT plans was assessed using the ArcCHECK and the Delta4 phantoms. The histograms represent the relative number of measured points (pass rate) which agreed with the calculated dose distribution within 3% of dose difference (%∆D) and 2 mm of distance to agreement (DTA). The measurements were performed with (A) the ArcCHECK and (B) the Delta4 phantom for the 15 IMRT, VMAT-91CP and VMAT-181CP plans. For the ArcCHECK results, the VMAT-91CP plan measurements were also compared to the dose distribution calculated with 181CPs (VMAT-91CP vs. VMAT-181CP).
Discussion
We confirmed that, for our 15 spine SBRT cases, that singlearc VMAT delivery improves delivery efficiency while generating at least equivalent target coverage and OAR sparing as compared to our IMRT technique. Within the 15 cases evaluated, we observe some outliers with significant gains favouring VMAT. For patient #2, the tumor was a C2 metastases with paraspinal extension, and the strict OAR to be spared included the oropharynx anteriorly and spinal cord posteriorly. For patient #14, the target was a metastases involving T12 to L2 where the strict OAR to be spared included the kidneys antero-laterally and the spinal cord/ thecal sac posteriorly. These were the most complex optimization problems in our series, and we postulate the inferior target coverage observed with IMRT plans may have been related to the limited degrees of freedom inherent to our standard 9-beam arrangement, with no manual optimizing of the gantry angle. The superior target coverage with VMAT support the hypothesis that VMAT acts as an inherent beam angle optimizer as proposed by Palma et al. (12) .
In terms of VMAT delivery efficiency, our results agree favourably with previous published studies (10, 14) with an average reduction in delivery time of 63% and 53% for our 91 and 181CP plans, and fewer MU required. We do acknowledge that the delivery time measurements in this study did not include human verification of beam parameters before delivery as performed in our clinical practice. However, this likely would only increase the favourable time delivery difference observed between VMAT and IMRT. With respect to multiple arc planning, our experience thus far has not supported this treatment planning approach (data not shown) unlike the report from Wu et al. We report that a single arc is sufficient for acceptable spine SBRT treatment planning as we observed equivalent and even better treatment planning metrics as compared to IMRT, with sufficient gains in delivery efficiency. Difference in TPS platform and maturity in the available planning tools might explain in part this contradictory conclusion.
Patient-specific QC of VMAT plans was also performed in this study using two different 3D dosimeters, and a major strength of this study. For the IMRT plans, the average pass rate for 3%/2 mm tolerances was 93.7% and 99.0% for the ArcCHECK and the Delta4, respectively. The difference in the average pass rate for these phantoms is related to the variation inherent to their geometry, and reflects the fact that dose measurements for a given plan are not performed at the same points in space. For VMAT, we observe improved planned-to-delivered agreement for 181CPs and 28CP gantry angular spacing as compared to 91CPs and 48CP gantry angular spacing. This observation is likely explained by an increased discretization effect in the TPS when the CP gantry angular spacing was 48. This discretization effect arises from the gantry angular resolution of the static beams used in the TPS to simulate the continuous arc delivered performed by the linear accelerator ( Figure 5 ). The 28CP gantry angular spacing requirement determined in this work is consistent with gantry angular resolution conditions determined in planning studies (11, 20) .
The discretization effect observed in the TPS with the CP gantry angular spacing had a clinically significant impact on the accuracy of dosimetric planning parameters as shown by the variation in D max-cord for patient #13, and both phantoms identified this issue for this patient. However, the ArcCHECK demonstrated a higher sensitivity than the Detla4 for more Figure 5 : On the first row, the beam eye views are shown for 4 control points (CPs) of the VMAT-91CP plan corresponding to gantry angle 2248, 2288, 2328 and 2368 for patient #13. The spinal cord and the planning target volume (PTV) are shown in green and red, respectively. The multileaf collimator aperture is overlaid. The second row, show the beam eye views for the corresponding CPs of the VMAT-181CP plan. Note that for the VMAT-91CP plan, the spinal cord is mostly shielded by the MLC while, for the VMAT-181CP plan, the spinal cord is directly exposed at the CP at 2308 of gantry angle. subtle variations in V 95% and D max-plan with the reduction in CP gantry angular spacing. Due to their location away from the isocenter, the ArcCHECK diodes are usually exposed in the open beam only for a small number of the CPs for a given VMAT plan. This limited amount of beam overlap at the location of the measurement points reduced the averaging effect generally associated with composite dose measurements and might explain the difference of sensitivity between these phantoms. Tolerances used in the planned-to-delivered dose agreement analysis also can affect the apparent phantom sensitivity to delivery errors. Based on these results and to avoid pitfalls related to TPS discretization effect, spine SBRT VMAT plans are now optimized in our institution with a 28CP gantry angular spacing.
Conclusion
We observe that single-arc VMAT significantly improves delivery efficiency by reducing treatment time while maintaining equivalent target coverage and OAR sparing as compared to IMRT. VMAT plans generated with a CP gantry angular spacing of 28 is recommended to avoid a discretization effect in the TPS and achieve acceptable planned-to-delivered dose agreement.
